Tech Company Financing Transactions

Cavion Funding Round

On 1/7/2017, Cavion announced $26.1 million in Series A funding from Lilly Ventures, Novartis Venture Fund and Enso Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

600 East Water St. E
Charlottesville, VA 22902
USA

Phone

(434) 200-8442

Website

www.cavionpharma.com

Email Address

[email protected]

Overview

Cavion is a clinical stage pharmaceutical company committed to providing patients with therapies for neurologic diseases and cancer through the development of drugs that selectively inhibit the T-type calcium channel (Cav3).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andrew Krouse

        

Chief Financial Officer

Kurt Woerpel

        

Chief Medical Officer

Spyros Papapetropoulos

        

VP - Bus. Development

Anne Heldreth

        

VP - Operations

Paul Sartori

        

Browse more venture capital transactions:

Prev: 1/7/2017: Arcadia Healthcare Solutions venture capital transaction
Next: 1/7/2017: PatientsLikeMe venture capital transaction

Share this article

News on VC Transactions

We do our best to record every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary